Send Inquiry
Description:
SFDA, CE Mark, ISO 13485, GMP manufactory
Drug Name
Naftopidil Dispersible Tablets
Composition
The main composition is naftopidil.
Description Tablets with white color.
Indication Anesis urinary obstructioncaused by benign hyperplasia of prostate.
Specification: 25mg
Dosage and Administration Orally. Initialcontent for adults are 1 pill/time, 1time/day. Take before sleep.Dosage can be adjusted as the clinical effectiveness(interval of1-2 weeks). Mix-dosage is 3 pills/day. Advanced age patients shouldtake 0.5pill/day as initial content and use carefully.
Storage
Stock in room temperature(10-30 degree). Sealed storage.
Package
Alu-plastic blister package. 8 tablets/bar, 1 bar/box.
Shelf Life
18 months
